CO6321280A2 - Nueva clase espiro piperidinas para el tratamiento de enfermedades neurodegenerativas - Google Patents

Nueva clase espiro piperidinas para el tratamiento de enfermedades neurodegenerativas

Info

Publication number
CO6321280A2
CO6321280A2 CO10141834A CO10141834A CO6321280A2 CO 6321280 A2 CO6321280 A2 CO 6321280A2 CO 10141834 A CO10141834 A CO 10141834A CO 10141834 A CO10141834 A CO 10141834A CO 6321280 A2 CO6321280 A2 CO 6321280A2
Authority
CO
Colombia
Prior art keywords
treatment
piperidinas
espiro
class
new
Prior art date
Application number
CO10141834A
Other languages
English (en)
Spanish (es)
Inventor
Michael Aaron Brodney
Christopher John Helal
Brian Thomas Oneill
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CO6321280A2 publication Critical patent/CO6321280A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CO10141834A 2008-05-05 2010-11-11 Nueva clase espiro piperidinas para el tratamiento de enfermedades neurodegenerativas CO6321280A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5042308P 2008-05-05 2008-05-05

Publications (1)

Publication Number Publication Date
CO6321280A2 true CO6321280A2 (es) 2011-09-20

Family

ID=40902870

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10141834A CO6321280A2 (es) 2008-05-05 2010-11-11 Nueva clase espiro piperidinas para el tratamiento de enfermedades neurodegenerativas

Country Status (22)

Country Link
US (1) US20110046160A1 (cg-RX-API-DMAC7.html)
EP (1) EP2300484B1 (cg-RX-API-DMAC7.html)
JP (1) JP2011519913A (cg-RX-API-DMAC7.html)
KR (1) KR20110000749A (cg-RX-API-DMAC7.html)
CN (1) CN102083841A (cg-RX-API-DMAC7.html)
AP (1) AP2010005456A0 (cg-RX-API-DMAC7.html)
AT (1) ATE537178T1 (cg-RX-API-DMAC7.html)
AU (1) AU2009245322B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0912433A2 (cg-RX-API-DMAC7.html)
CA (1) CA2721786A1 (cg-RX-API-DMAC7.html)
CO (1) CO6321280A2 (cg-RX-API-DMAC7.html)
CR (1) CR11759A (cg-RX-API-DMAC7.html)
DO (1) DOP2010000317A (cg-RX-API-DMAC7.html)
EA (1) EA201001566A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP10010597A (cg-RX-API-DMAC7.html)
ES (1) ES2375913T3 (cg-RX-API-DMAC7.html)
IL (1) IL208793A0 (cg-RX-API-DMAC7.html)
MA (1) MA32290B1 (cg-RX-API-DMAC7.html)
MX (1) MX2010012066A (cg-RX-API-DMAC7.html)
NZ (1) NZ588589A (cg-RX-API-DMAC7.html)
SV (1) SV2010003725A (cg-RX-API-DMAC7.html)
WO (1) WO2009136350A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
UA108363C2 (uk) 2009-10-08 2015-04-27 Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
EP2556076A2 (en) * 2010-04-09 2013-02-13 Pfizer Inc. Novel sultam compounds
WO2012138734A1 (en) 2011-04-07 2012-10-11 Merck Sharp & Dohme Corp. C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
EP2694521B1 (en) 2011-04-07 2015-11-25 Merck Sharp & Dohme Corp. Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
RU2014111055A (ru) 2011-08-22 2015-09-27 Мерк Шарп И Доум Корп. 2-спирозамещенные иминотиазины и их моно- и диоксиды в качестве ингибиторов bace, композиции и их применение
EP3233799B1 (en) 2014-12-19 2021-05-19 The Broad Institute, Inc. Dopamine d2 receptor ligands
EP3233077B1 (en) 2014-12-19 2026-05-06 The Broad Institute, Inc. Dopamine d2 receptor ligands

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2359707T3 (es) * 2004-01-08 2011-05-26 F. Hoffmann-La Roche Ag Derivados de diaza-espiropiperidina.
JP2006044497A (ja) * 2004-08-05 2006-02-16 Toyota Motor Corp 車輪情報処理装置
WO2006044497A2 (en) * 2004-10-13 2006-04-27 Merck & Co., Inc. Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer’s disease
CA2615656A1 (en) * 2005-07-18 2007-01-25 Merck & Co., Inc. Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
WO2008030412A2 (en) * 2006-09-07 2008-03-13 Merck & Co., Inc. Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
EP2117309B1 (en) * 2007-01-04 2013-11-06 Merck Sharp & Dohme Corp. Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease

Also Published As

Publication number Publication date
ECSP10010597A (es) 2010-12-30
CA2721786A1 (en) 2009-11-12
IL208793A0 (en) 2010-12-30
MX2010012066A (es) 2010-12-06
CR11759A (es) 2010-11-22
AU2009245322B2 (en) 2011-07-14
AP2010005456A0 (en) 2010-12-31
CN102083841A (zh) 2011-06-01
NZ588589A (en) 2012-07-27
MA32290B1 (fr) 2011-05-02
AU2009245322A1 (en) 2009-11-12
KR20110000749A (ko) 2011-01-05
DOP2010000317A (es) 2010-11-15
BRPI0912433A2 (pt) 2015-12-22
EA201001566A1 (ru) 2011-04-29
WO2009136350A1 (en) 2009-11-12
US20110046160A1 (en) 2011-02-24
EP2300484B1 (en) 2011-12-14
JP2011519913A (ja) 2011-07-14
EP2300484A1 (en) 2011-03-30
ES2375913T3 (es) 2012-03-07
SV2010003725A (es) 2011-07-05
ATE537178T1 (de) 2011-12-15

Similar Documents

Publication Publication Date Title
UY30500A1 (es) Compuestos de azabencimidazolilo
UY31189A1 (es) Compuestos heterocíclicos
UY32977A (es) Novedosos compuestos como inhibidores de la caseina quinasa
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
ECSP11011073A (es) Nuevas lactamas como inhibidores de beta secretasa
UY33921A (es) Oxazinopteridinas y oxazinoptiridinonas n-sustituidas
CL2012001911A1 (es) Compuestos derivados de fumarato; composicion farmaceutica que los comprende; y su uso en el tratamiento de una enfermedad inflamatoria o neurodegenerativa.
CY1118379T1 (el) Αναστολεις ιου ηπατιτιδας c
UY33536A (es) INHIBIDORES BICÍCLICOS DE ACETIL-CoA-CARBOXILASA Y USOS DE LOS MISMOS
CR20110680A (es) Sulfonamidas heterociclicas, usos y composiciones farmacéuticas de las mismas
CU20110207A7 (es) Aril piridinas como inhibidoras de sintasa de aldosterona
CR11819A (es) Compuestos de isoindolina 5-sustituidos
CY1118662T1 (el) Νεες δικυκλικες πυριδινονες
CU20110145A7 (es) Derivados de sulfonamida
UY33075A (es) Derivados de ciclohexano y usos de los mismos
ECSP13012611A (es) Derivados de pirazol-aminopirimidina como moduladores de la lrrk2
EA201500298A1 (ru) Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы
UY31885A (es) Derivados de las 1, 3, 5-triazina-2, 4-diaminas-6-sustituidas-n-sustituidas y sales farmacéuticamente aceptables de los mismos, composiciones y aplicaciones.
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
CR20140399A (es) Pirrolidina-2-carboxamidas sustituidas
UY31870A (es) Receptor metabotrópico de glutamato potenciadores 286
ECSP10010597A (es) Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas
UY33348A (es) Compuestos de furopiridina y usos de los mismos
CU20110108A7 (es) [4-(1-amino-etil)-ciclohexil]-metil-aminas como antibacterianos
CR20120131A (es) Uso de derivados del indol como activadores de nurr-1, para su aplicación como medicamento en el tratamiento de la enfermedad de parkinson

Legal Events

Date Code Title Description
FA Application withdrawn